I agree - that is exactly what I thought the most likely
I agree - that is exactly what I thought the most likely outcome would be from DSUS Day 1. The first thing I did was use the true cost basis of the old company based on the qty of r/s shares, look at the average, ignore the certs and treat that as a bonus, and buy new DSUS shares to get the average to a no-brainer price that it will without doubt exceed very quickly.
Those who got duped into selling their shares by the nonsense posted elsewhere took a huge loss because they just looked at the cash they would get as their brokers showed the cost basis of the r/s shares as $0 which of course it was not. In reality they got less than .0001 (in old company money) if they sold.
The original cert plan was based on a resolution by the BOD of the old company. I do not see why the new BOD can't extend the deadline. Contrary to posts elsewhere, it was always up to the BOD when redemption on the old plan would take place within the earliest and latest date window (my reading of the conditions anyway).
Personally I'm happy to wait until the pps is over $.2 - as stated by others, verified longs hold a significant portion of the float and they will not be selling any time soon.
Drone Services USA Inc (DSUS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Top 5 Most Recently Viewed Articles
Deere settles SEC bribery case for $9.93 million Deere (NYSE: DE) has agreed to pay $9.93 million to the U.S. Securities and Exchange Commission (SEC) to resolve a Foreign Corrupt Practices Act (FCPA) matter. The action closes a significant investigation and underscores how complex it can be for global companies to operate across borders while meeting U.S. and local rules...
Continue Reading
IperionX Limited Quarterly Update: Key Highlights CHARLOTTE, N.C. - IperionX Limited (NASDAQ: IPX, ASX: IPX) shares its quarterly report, highlighting significant progress achieved up to June 30, 2025. This period marks a transformative phase in the company, underlining a commitment to sustainable practices and growth in the titanium industry. Advancements in Commercial...
Continue Reading
Generate:Biomedicines and Novartis Announce Partnership Generate:Biomedicines is thrilled to share its new collaboration with Novartis, aiming to harness its cutting-edge generative AI platform to discover protein therapeutics. This partnership is set to address various disease areas by developing potential first- and best-in-class therapeutic molecules. Revolutionizing...
Continue Reading
Dr. David Salehani Hosts Exclusive Study Club Event Dr. David Salehani is excited to host a specialized Study Club dedicated to the dental community. This exclusive event features Dr. Storm Hagen, a prominent expert in the field of digital dentistry, and will include a captivating lecture on 3D printing and digital workflows in modern dentistry. Attendees can expect an...
Continue Reading
Free Health Screenings for Cholesterol Detection in Orlando In a significant health initiative, Care Access is bringing its Heart & Kidney Health Screening program to residents of Orlando. This innovative approach is designed to enhance awareness and provide testing for crucial health risk factors, particularly focusing on a dangerous type of cholesterol known as...
Continue Reading
